Turning Point Brands, Inc. — Form 8-K
Filed August 4, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 62/100
What the filing says
Turning Point Brands reported Q2 2026 net sales of $142.9M (up 22.6% YoY), with Modern Oral (FRE and ALP brands) net sales jumping to $68.4M from $30.5M YoY (128% growth), now representing 48% of total sales vs. 26% prior year. Company raised FY 2026 Modern Oral net sales guidance to $260–$270M from $210–$225M and Adjusted EBITDA to $70–$90M. However, net income fell 75.2% to $3.6M and Adjusted EBITDA fell 50% to $15.2M in Q2 due to heavy strategic SG&A investments ($76.9M, up 91%) and gross margin compression in Modern Oral. The company raised $59.6M in equity in the quarter.
Why this rating
Modern Oral scaling 128% with guidance raised is material to growth narrative; but Q2 profits collapsed and guidance remains low relative to sales. Equity dilution and margin pressure offset near-term; significant for trajectory but earnings deterioration is real headwind.
See more from August 4, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.